1. IMS MIDAS DATA. 2009. http://www.multivu.prnewswire.com/mnr/GPhA/38110/docs/38110-734_Billion_in_Generic_Savings_GPhA.pdf . Accessed 20 May 2012.
2. Treur M, Heeg B, Möller HJ, et al. A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. BMC Health Serv Res. 2009;18(9):32.
3. National Cancer Institute. Levels of Evidence for Adult and Pediatric Cancer Treatment (PDQ®). http://www.cancer.gov/cancertopics/pdq/levels-evidence-adult-treatment/HealthProfessional/page2 . Accessed 5 Sept 2012.
4. Food and Drug Administration. Facts About Generic Drugs. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm167991.htm . Accessed 5 Sept 2012.
5. Food and Drug Administration. Approved Drug Products With Therapeutic Equivalence Evaluations. 32th ed. 2012. http://www.fda.gov/cder/orange/obannual.pdf . Accessed 06 Sept 2012.